Slingshot Insights | Kymr Overview

KYMR Overview

Upcoming Projects (KYMR)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (KYMR)

A second look: Discussing the potential of KT-474 and it's Phase 1 results which provide the first clinical validation for targeting the IRAK4 pathway with a degrader in TLR/IL-1R-driven inflammatory diseases such as atopic dermatitis
Tickers: KYMR, SNY
Executed On: Jan 03, 2023 at 08:15 PM EST
Discussing the potential of KT-474 and it's Phase 1 results which provide the first clinical validation for targeting the IRAK4 pathway with a degrader in TLR/IL-1R-driven inflammatory diseases such as atopic dermatitis
Tickers: KYMR, SNY
Executed On: Dec 19, 2022 at 03:45 PM EST
Discussing protein degraders in the oncology space
Tickers: ARVN, CCCC, NRIX, KYMR
Executed On: Jan 05, 2022 at 02:00 PM EST

Upcoming & Overdue Catalysts (KYMR)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (KYMR)

Don’t see a strategic initiative related to the company you care about? Create your own!